Lexaria Research Development from 2010 to 2026

LEXX Stock  USD 0.78  0.03  3.70%   
Lexaria Bioscience Research Development yearly trend continues to be fairly stable with very little volatility. Research Development is likely to outpace its year average in 2026. During the period from 2010 to 2026, Lexaria Bioscience Research Development regression line of annual values had r-squared of  0.65 and arithmetic mean of  2,295,629. View All Fundamentals
 
Research Development  
First Reported
2014-11-30
Previous Quarter
1.9 M
Current Value
671.3 K
Quarterly Volatility
619.2 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 190.8 K, Interest Expense of 107 K or Total Revenue of 426.9 K, as well as many indicators such as Price To Sales Ratio of 110, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Build AI portfolio with Lexaria Stock
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Research Development Growth Pattern

Below is the plot of the Research Development of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Lexaria Research Development Regression Statistics

Arithmetic Mean2,295,629
Geometric Mean561,400
Coefficient Of Variation150.84
Mean Deviation2,613,032
Median492,864
Standard Deviation3,462,695
Sample Variance12T
Range9.9M
R-Value0.81
Mean Square Error4.5T
R-Squared0.65
Significance0.000097
Slope552,032
Total Sum of Squares191.8T

Lexaria Research Development History

20269.9 M
20259.5 M
20248.2 M
20232.4 M
20223.7 M
20211.8 M
20201.3 M

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development9.5 M9.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.